Role of oxidative stress and the mitochondrial permeability transition in methylmercury cytotoxicity. 2011

Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
Neurotoxicology Laboratories, Department of Pharmacology and Toxicology, Rutgers University, Piscataway, NJ 08854, United States.

Oxidative stress has been implicated in the pathogenesis of methylmercury (MeHg) neurotoxicity. Studies of mature neurons suggest that the mitochondrion may be a major source of MeHg-induced reactive oxygen species and a critical mediator of MeHg-induced neuronal death, likely by activation of apoptotic pathways. It is unclear, however, whether the mitochondria of developing and mature neurons are equally susceptible to MeHg. Murine embryonal carcinoma (EC) cells, which differentiate into neurons following exposure to retinoic acid, were used to compare the differentiation-dependent effects of MeHg on ROS production and mitochondrial depolarization. EC cells and their neuronal derivatives were pre-incubated with the ROS indicator 2',7'-dichlorofluoroscein diacetate or tetramethylrhodamine methyl ester, an indicator of mitochondrial membrane potential, with or without cyclosporin A (CsA), an inhibitor of mitochondrial permeability transition pore opening, and examined by laser scanning confocal microscopy in the presence of 1.5 μM MeHg. To examine consequences of mitochondrial perturbation, immunohistochemical localization of cytochrome c (cyt c) was determined after incubation of cells in MeHg for 4 h. MeHg treatment induced earlier and significantly higher levels of ROS production and more extensive mitochondrial depolarization in neurons than in undifferentiated EC cells. CsA completely inhibited mitochondrial depolarization by MeHg in EC cells but only delayed this response in the neurons. In contrast, CsA significantly inhibited MeHg-induced neuronal ROS production. Cyt c release was also more extensive in neurons, with less protection afforded by CsA. These data indicate that neuronal differentiation state influences mitochondrial transition pore dynamics and MeHg-stimulated production of ROS.

UI MeSH Term Description Entries
D007425 Intracellular Membranes Thin structures that encapsulate subcellular structures or ORGANELLES in EUKARYOTIC CELLS. They include a variety of membranes associated with the CELL NUCLEUS; the MITOCHONDRIA; the GOLGI APPARATUS; the ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES. Membranes, Intracellular,Intracellular Membrane,Membrane, Intracellular
D008767 Methylmercury Compounds Organic compounds in which mercury is attached to a methyl group. Methyl Mercury Compounds,Compounds, Methyl Mercury,Compounds, Methylmercury,Mercury Compounds, Methyl
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053078 Membrane Potential, Mitochondrial The voltage difference, normally maintained at approximately -180mV, across the INNER MITOCHONDRIAL MEMBRANE, by a net movement of positive charge across the membrane. It is a major component of the PROTON MOTIVE FORCE in MITOCHONDRIA used to drive the synthesis of ATP. Delta Psi M,DeltaPsi M,DeltapsiM,Mitochondrial Membrane Potential,Mitochondrial Transmembrane Potential,M, DeltaPsi,Membrane Potentials, Mitochondrial,Mitochondrial Membrane Potentials,Mitochondrial Transmembrane Potentials,Transmembrane Potential, Mitochondrial,Transmembrane Potentials, Mitochondrial

Related Publications

Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
April 2001, FEBS letters,
Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
December 2011, Free radical biology & medicine,
Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
July 2005, Neurochemistry international,
Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
April 2006, Free radical biology & medicine,
Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
January 2000, Free radical biology & medicine,
Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
August 2020, Antioxidants (Basel, Switzerland),
Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
December 2014, Molecules (Basel, Switzerland),
Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
June 1997, Cancer research,
Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
November 2005, Toxicology and applied pharmacology,
Marianne Polunas, and Alycia Halladay, and Ronald B Tjalkens, and Martin A Philbert, and Herbert Lowndes, and Kenneth Reuhl
February 2005, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!